CYP cynata therapeutics limited

9.68%

17.0¢

CYP 2021 - The year ahead, page-85

First 85 Last

Share
Profile

Follow
Barman76

4,013 Posts.

315

21/01/21

20:35

Post #: 50354873
Share

Originally posted by elvisj: ↑

1. i've read the Nature article and I don't see that anywhere. Can you please point out where it says that (in the article, I don't want a reference to what you or any other poster made up and may have posted on here previously). Somehow I don't think you'll be able to.
2. manufacturing is outsourced. Fuji recently announced an additional $2bn cell manufacturing plant to add to their existing plants, somehow I don't think it's to produce 1,200 doses.

Already know you don't have a factual answer so back on ignore.

Sigmadelta, good question, i'd also like to know but I don't think anyone knows the answer until phase 3 trials are complete and regulatory approvals and large manufacturing quantities need to be negotiated. Clearly the cells for the OA trial didn't make a huge dent in cash flow but this was only 100s of recipients. We also don't know what our product would sell for which I expect will be influenced by manufacturing costs. One benchmark we have is MSB is selling GvHD for I believe $250k per patient but I expect this fee will come down enormously over time, particularly as manufacturing efficiencies increase.

Expand

you ask a question and then put me back on ignore. That’s really funny!

we discussed this, you and everyone else was silent. And that is very telling!

so if I’m wrong, how many can you produce this year? How long did it take to get the current doses on hand?

another who can’t answer a question with mentioning MSB.

25500 years lol

god I love HC

CYP Price at posting: 69.0¢ Sentiment: Hold Disclosure: Not Held
1 Upvote

0 Great analysis

Reply

Top Stories

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

RMX

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

SRL

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

AII

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

MVF

Monash IVF shares cater 25% – Disaster or deep-value play?

First 85 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 17.0¢		Change 0.015(9.68%)		Mkt cap ! $38.41M

Open	High	Low	Value	Volume
15.5¢	17.0¢	15.5¢	$47.10K	289.1K

Buyers (Bids)

No.	Vol.	Price($)
1	50000	16.5¢

Sellers (Offers)

Price($)	Vol.	No.
17.0¢	23813	3

View Market Depth

No.	Vol.	Price($)
1	50000	0.165
4	47240	0.155
4	161673	0.150
1	5000	0.145
2	45000	0.140

Price($)	Vol.	No.
0.170	18813	2
0.175	55250	1
0.180	62619	3
0.185	35990	1
0.195	19300	1

Last trade - 16.10pm 27/06/2025 (20 minute delay)

CYP (ASX) Chart

CYP 2021 - The year ahead, page-85

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Australia’s gas crisis is here – and dying coal plants aren’t helping

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Monash IVF shares cater 25% – Disaster or deep-value play?

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

CYP 2021 - The year ahead, page-85

Top Stories

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Australia’s gas crisis is here – and dying coal plants aren’t helping

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Monash IVF shares cater 25% – Disaster or deep-value play?

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News